Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

NCT05070650 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Sandoz has decided to withdraw the clinical study due to internal business reasons. No patients were enrolled in any of the participating countries.

Conditions

Interventions

Sponsor

Sandoz